Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Exenatide: Phase II; Phase III

In a 5-day, placebo-controlled U.S. Phase II study in

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE